The detection of pfcrt and pfmdr1 point mutations as molecular markers of chloroquine drug resistance, Pahang, Malaysia

Malaria Journal

Volumn 11, Issue , 2012, Pages

  Atroosh, Wahib M ^a   Al Mekhlafi, Hesham M ^a,b   Mahdy, Mohammed A K ^a,b   Surin, Johari ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b SANA A UNIVERSITY   (Yemen)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; ASPARTIC ACID; CHLOROQUINE; ISOLEUCINE; LYSINE; MEMBRANE PROTEIN; MOLECULAR MARKER; PFCRT PROTEIN; PFMDR1 PROTEIN; SERINE; THREONINE; UNCLASSIFIED DRUG;

ADULT; AMINO ACID SUBSTITUTION; ANTIMALARIAL DRUG RESISTANCE; ARTICLE; BLOOD SAMPLING; CODON; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ENDEMIC DISEASE; FEMALE; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALAYSIA; MALE; PARASITE PREVALENCE; PLASMODIUM FALCIPARUM; POINT MUTATION; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; WILD TYPE;

ADULT; ANTIMALARIALS; CHLOROQUINE; DNA, PROTOZOAN; DRUG RESISTANCE; FEMALE; HUMANS; MALARIA, FALCIPARUM; MALAYSIA; MALE; MEMBRANE TRANSPORT PROTEINS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PLASMODIUM FALCIPARUM; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROTOZOAN PROTEINS;

EID: 84864398724     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-11-251     Document Type: Article

References (47)

1. WHO, World Malaria Report 2010 Geneva: World Health Organization 2010
2. Drug resistance in Plasmodium falciparum from Thailand. Young MD, Contacos PG, Stitcher JE, Millar JW, Am J Trop Med Hyg 1963 12 305 314 14044740
3. Chloroquine resistant falciparum malaria in Thailand. Harinasuta T, Suntharasamai P, Viravan C, Lancet 1965 ii 657 660
4. Chloroquine resistant malaria in Papua New Guinea. Grimmond TR, Donovan KO, Riley ID, P NG Med J 1976 19 184 185 21509236 (Pubitemid 8111126)
5. Observations on two Plasmodium falciparum infections with an abnormal response to chloroquine. Moore DV, Lanier JE, Am J Trop Med Hyg 1961 10 5 9 13772281
6. Chloroquine-resistant Plasmodium falciparum malaria in Kenya. Fogh S, Jepsen S, Effersoe P, Trans R Soc Trop Med Hyg 1979 73 228 229 10.1016/0035-9203(79)90220-7 382468 (Pubitemid 9159413)
7. The problem of Plasmodium falciparum drug resistance in Africa south of the Sahara. Onori E, Bull World Health Organ 1984 62 Suppl 55 62 6397277 (Pubitemid 15165246)
8. Chloroquine-resistant falciparum malaria from Malawi. Overbosch D, van den Wall Bake AW, Stuiver PC, van der Kaay HJ, Trop Geogr Med 1984 36 71 72 6375051 (Pubitemid 14024962)
9. Peters W, Chemotherapy and drug resistance in malaria, 2nd ed edn New York: Academic Press, Inc. 1987
10. Mefloquine-resistant falciparum malaria on the Thai-Burmese border. Nosten F, Kuile F, Chongsuphajaisiddhi T, Luxemburger C, Webster HK, Edstein M, Phaipun L, Thew KL, White NJ, Lancet 1991 337 1140 1143 10.1016/0140-6736(91) 92798-7 1674024
11. Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand. Looareesuwan S, Viravan C, Webster HK, Kyle DE, Hutchinson DB, Canfield CJ, Am J Trop Med Hyg 1996 54 62 66 8651372 (Pubitemid 26045736)
12. Artemisinin resistance in Plasmodium falciparum malaria. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwong M, Chotivanich K, Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NP, Lindegardh N, Socheat D, White NJ, N Eng J Med 2009 361 455 467 10.1056/NEJMoa0808859
13. Epidemiology of drug-resistant malaria. Wongsrichanalai C, Pickard AL, Wernsdorfer WH, Meshnick SR, Lancet Infect Dis 2002 2 209 218 10.1016/S1473-3099(02)00239-6 11937421 (Pubitemid 34464751)
14. A molecular marker for chloroquine-resistant falciparum malaria. Djimde A, Doumbo OK, Cortese JF, Kayentao K, Doumbo S, Diourte Y, Coulibaly D, Dicko A, Su XZ, Nomura T, Fidock DA, Wellems TE, Plowe CV, N Eng J Med 2001 344 257 263 10.1056/NEJM200101253440403 (Pubitemid 32108530)
15. Application of a multi-faceted approach for the assessment of treatment response in falciparum malaria: A study from Malaysian Borneo. Cox-Singh J, Lu HY, Davis TME, Ilett KF, Hackett LP, Matusop A, Singh B, Int J Parasitol 2003 33 1545 1552 10.1016/S0020-7519(03)00199-1 14572517 (Pubitemid 37324192)
16. Plasmodium falciparum: increased proportion of severe resistance (RII and RIII) to chloroquine and high rate of resistance to sulfadoxine-pyrimethamine in Peninsular Malaysia after two decades. Hakim SL, Roohi SWAS, Zurkurnai Y, Rain AN, Mansor SM, Palmer K, Navaratnam V, Mak JW, Trans R Soc Trop Med Hyg 1996 90 294 297 10.1016/S0035-9203(96)90258-8 8758083 (Pubitemid 26188881)
17. Molecular markers of resistance to sulphadoxine-pyrimethamine one year after implementation of intermittent preventive treatment of malaria in infants in Mali. Dicko A, Sagara I, Djimde AA, Toure SO, Traore M, Dama S, Diallo AI, Barry A, Dicko M, Coulibaly OM, Rogier C, de Sousa A, Doumbo OK, Malar J 2010 9 9 10.1186/1475-2875-9-9 20064223
18. A genus- and species-specific nested polymerase chain reaction malaria detection assay for epidemiologic studies. Singh B, Bobogare A, Cox-Singh J, Snounou G, Abdullah M, Rahman H, Am J Trop Med Hyg 1999 60 687 692 10348249 (Pubitemid 29233131)
19. High frequency of Plasmodium falciparum chloroquine resistance marker (pfcrt T76 mutation) in Yemen: an urgent need to re-examine malaria drug policy. Al-Mekhlafi AM, Mahdy MA, Al-Mekhlafi HM, Azazy AA, Fong MY, Parasit Vectors 2011 4 94 10.1186/1756-3305-4-94 21619624
20. Molecular characterisation of drug-resistant Plasmodium falciparum from Thailand. Lopes D, Rungsihirunrat K, Nogueira F, Seugorn A, Gil JP, do Rosario VE, Cravo P, Malar J 2002 1 12 10.1186/1475-2875-1-12 12423551
21. Association between chloroquine resistance phenotypes and point mutations in pfcrt and pfmdr1 in Plasmodium falciparum isolates from Thailand. Rungsihirunrat K, Chaijareonkul W, Seugorn A, Na-Bangchang K, Thaithong S, Acta Trop 2009 109 37 40 10.1016/j.actatropica.2008.09.011 18950599
22. The T76 mutation in the pfcrt gene of Plasmodium falciparum and clinical chloroquine resistance phenotypes in Papua, Indonesia. Maguire JD, Susanti AI, Krisin Sismadi P, Fryauff DJ, Baird JK, Ann Trop Med Parasitol 2001 95 559 572 10.1080/00034980120092516 11672462 (Pubitemid 32928077)
23. Association of molecular markers in Plasmodium falciparum crt and mdr1 with in vitro chloroquine resistance: A Philippine study. Hatabu T, Iwagami M, Kawazu S, Taguchi N, Escueta AD, Villacorte EA, Rivera PT, Kano S, Parasitol Int 2009 58 166 170 10.1016/j.parint.2009.01.010 19567229
24. In vivo chloroquine responses and pfcrt polymorphisms in Bandiagara, Mali. Djimde A, Doumbo O, Kayentao K, Doumbo S, Diourte Y, Coulibaly D, Cortese J, Su X, Fidock D, Nomura T, Wellems T, Plowe C, Am J Trop Med Hyg 1999 61 supplement 335 336
25. Polymorphisms in the Plasmodium falciparum pfcrt and pfmdr-1 genes and clinical response to chloroquine in Kampala, Uganda. Dorsey G, Kamya MR, Singh A, Rosenthal PJ, J Infect Dis 2001 183 1417 1420 10.1086/319865 11294677 (Pubitemid 32337128)
26. High-level chloroquine resistance in Sudanese isolates of Plasmodium falciparum is associated with mutations in the chloroquine resistance transporter gene pfcrt and the multidrug resistance gene pfmdr1. Babiker HA, Pringle SJ, Abdel-Muhsin A, Mackinnon M, Hunt P, Walliker D, J Infect Dis 2001 183 1535 1538 10.1086/320195 11319692 (Pubitemid 32417707)
27. The Lys-76-Thr mutation in pfcrt and chloroquine resistance in Plasmodium falciparum isolates from Uganda. Kyosiimire-Lugemwa J, Nalunkuma-Kazibwe AJ, Mujuzi G, Mulindwa H, Talisuna A, Egwang TG, Trans R Soc Trop Med Hyg 2002 96 91 95 10.1016/S0035-9203(02)90252-X 11926004 (Pubitemid 34846542)
28. Variations in the sequence and expression of the Plasmodium falciparum chloroquine resistance transporter (pfcrt) and their relationship to chloroquine resistance in vitro. Durrand V, Berry A, Sem R, Glaziou P, Beaudou J, Fandeur T, Mol Biochem Parasitol 2004 136 273 285 10.1016/j.molbiopara.2004.03.016 15478806 (Pubitemid 38757996)
29. Pfcrt polymorphism and chloroquine resistance in Plasmodium falciparum strains isolated in Cambodia. Lim P, Chy S, Ariey F, Incardona S, Chim P, Sem R, Denis MB, Hewitt S, Hoyer S, Socheat D, Merecreau-Puijalon O, Fandeur T, Antimicrob Agents Chemother 2003 47 87 94 10.1128/AAC.47.1.87-94.2003 12499174 (Pubitemid 36070347)
30. Mutations in the Plasmodium falciparum digestive vacuole transmembrane protein pfcrt and evidence for their role in chloroquine resistance. Fidock DA, Nomura T, Talley AK, Cooper RA, Dzekunov SM, Ferdig MT, Ursos LMB, Sidhu AS, Naude B, Deitsch KW, Su XZ, Wootton JC, Roepe PD, Wellems TE, Mol Cell 2000 6 861 871 10.1016/S1097-2765(05)00077-8 11090624
31. Chloroquine-resistant Plasmodium falciparum isolates from the Sudan lack two mutations in the pfmdr1 gene thought to be associated with chloroquine resistance. Awad-El-Kariem FM, Miles MA, Warhurst DC, Trans R Soc Trop Med Hyg 1992 86 587 589 10.1016/0035-9203(92)90140-8 1287907 (Pubitemid 23012895)
32. Analysis of pfmdr1 and drug susceptibility in fresh isolates of Plasmodium falciparum from Subsaharan Africa. Basco LK, Bras JL, Rhoades Z, Wilson CM, Mol Biochem Parasitol 1995 74 157 166 10.1016/0166-6851(95)02492-1 8719157 (Pubitemid 26024474)
33. Polymorphism of the pfmdr1 gene and chloroquine resistance in Plasmodium falciparum in the Gambia. von Seidlein L, Duraisingh MT, Drakeley CJ, Bailey R, Greenwood BM, Pinder M, Trans R Soc Trop Med Hyg 1997 91 450 453 10.1016/S0035-9203(97)90281-9 9373652 (Pubitemid 27421240)
34. Association of pfcrt but not pfmdr1 alleles with chloroquine resistance in Iranian isolates of Plasmodium falciparum. Zakeri S, Afsharpad M, Kazemzadeh T, Mehdizadeh K, Shabani A, Djadid ND, Am J Trop Med Hyg 2008 78 633 640 18385361 (Pubitemid 351845169)
35. Chloroquine clinical failures in Plasmodium falciparum malaria are associated with mutant pfmdr-1, not pfcrt in Madagascar. Andriantsoanirina V, Ratsimbasoa A, Bouchier C, Tichit M, Jahevitra M, Rabearimanana S, Raherinjafy R, Mercereau-Puijalon O, Durand R, Menard D, PLoS One 2010 5 13281 10.1371/journal.pone.0013281 20967251
36. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Reed MB, Saliba KJ, Caruana SR, Kirk K, Cowman AF, Nature 2000 403 906 909 10.1038/35002615 10706290 (Pubitemid 30130994)
37. The pfmdr1 gene is associated with a multidrug-resistant phenotype in Plasmodium falciparum from the western border of Thailand. Price RN, Cassar C, Brockman A, Duraisingh M, van Vugt M, White NJ, Nosten F, Krishna S, Antimicrob Agents Chemother 1999 43 2943 2949 10582887
38. Association between mutations in Plasmodium falciparum chloroquine resistance transporter and Plasmodium falciparum multidrug resistance 1 genes and in vivo amodiaquine resistance in Plasmodium falciparum malaria-infected children in Nigeria. Happi CT, Gbotosho GO, Folarin OA, Bolaji OM, Sowunmi A, Kyle DE, Milhous W, Wirth DF, Oduola AM, Am J Trop Med Hyg 2006 75 155 161 16837724 (Pubitemid 351627586)
39. Chloroquine-resistance molecular markers (pfcrt T76 and pfmdr-1 Y86) and amodiaquine resistance in Burkina Faso. Tinto H, Guekoun L, Zongo I, Guiguemde RT, DAlessandro U, Ouedraogo JB, Trop Med Int Health 2008 13 238 240 10.1111/j.1365-3156.2007.01995.x 18304270 (Pubitemid 351316975)
40. Limited ability of Plasmodium falciparum pfcrt, pfmdr1, and pfnhe1 polymorphisms to predict quinine in vitro sensitivity or clinical effectiveness in Uganda. Baliraine FN, Nsobya SL, Achan J, Tibenderana JK, Talisuna AO, Greenhouse B, Rosenthal PJ, Antimicrob Agents Chemother 2011 55 615 622 10.1128/AAC.00954-10 21078941
41. Increased sensitivity to the antimalarials mefloquine and artemisinin is conferred by mutations in the pfmdr1 gene of Plasmodium falciparum. Duraisingh MT, Roper C, Walliker D, Warhurst DC, Mol Microbiol 2000 36 955 961 10.1046/j.1365-2958.2000.01914.x 10844681 (Pubitemid 30326539)
42. Pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum. Sidhu ABS, Valderramos SG, Fidock DA, Mol Microbiol 2005 57 913 926 10.1111/j.1365-2958.2005.04729.x 16091034 (Pubitemid 41139856)
43. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Price RN, Uhlemann A-C, Brockman A, McGready R, Ashley E, Phaipun L, Patel R, Laing K, Looareesuwan S, White NJ, Nosten F, Krishna S, Lancet 2004 364 438 447 10.1016/S0140-6736(04)16767-6 15288742 (Pubitemid 39036891)
44. The roles of the pfcrt 76T and pfmdr1 86Y mutations, immunity and the initial level of parasitaemia, in predicting the outcome of chloroquine treatment in two areas with different transmission intensities. Khalil IF, Alifrangis M, Tarimo DS, Staalso T, Satti GMH, Theander TG, Ronn AM, Bygbjerg IC, Ann Trop Med Parasitol 2005 99 441 448 10.1179/136485905X46441 16004703 (Pubitemid 40992388)
45. Association of Plasmodium falciparum chloroquine resistance transporter variant t76 with age-related plasma chloroquine levels. May J, Meyer CG, Am J Trop Med Hyg 2003 68 143 146 12641402 (Pubitemid 38240536)
46. Drug resistance-virulence relationship in Plasmodium falciparum causing severe malaria in an area of seasonal and unstable transmission. Giha HA, Elbashir MI, A-Elbasit IE, A-Elgadir TME, ElGhazali GE, Mackinnon MJ, Babiker HA, Acta Trop 2006 97 181 187 10.1016/j.actatropica.2005.10.004 16336938 (Pubitemid 43087752)
47. No variation in the prevalence of point mutations in the pfcrt and pfmdr1 genes in isolates from Gabonese patients with uncomplicated or severe Plasmodium falciparum malaria. Mayengue P, Kalmbach Y, Issifou S, Kremsner P, Ntoumi F, Parasitol Res 2007 100 487 493 17096149 (Pubitemid 46011259)